ProImmune Ltd, a global leader in life science reagents and services, announced the launch of its new ProVE SL self-loading MHC Class I monomers. The novel reagents for antigen-specific CD8+ T cell ...

Ascletis Pharma Inc announced that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical development candidate. Ascletis ...

Positive results from the global PREVAIL phase III trial showed that gefurulimab met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement from baseline ...

PharmaDrug Inc, a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines, announced that it has executed a definitive securities exchange ...

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the ...

Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, announced that it has submitted an unsolicited proposal to acquire Metsera, Inc. The acquisition of ...

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of its new Neurotoxicity Testing Services; expanding its established neuroscience discovery ...

The menace of counterfeit medicines has been a major issue the world has been facing for a long time now, and the Indian market was no exception. The front pages of the Indian newspapers have very ...

SpectronRx commences mass production of high-purity Actinium-225, to strengthen global supply for cancer therapies: Indiana Saturday, November 1, 2025, 15:00 Hrs [IST] SpectronRx, ...

Codexis & Nitto Denko Avecia ink evaluation agreement to explore Codexis’s ECO Synthesis Manufacturing Platform for therapeutic siRNA manufacturing: Redwood City, California Sat ...

How will our healthcare sector be in 2050? Let us imagine. Present trends and happenings forecast what is in store for us in the future. There will be lakhs of doctors, nurses, pharmacists and lab ...

REGENXBIO completes pivotal enrollment and initiates commercial production in Duchenne gene therapy programme: Rockville, Maryland Friday, October 31, 2025, 18:00 Hrs [IST] REGENX ...